Evidence map›Paper›PMID 37700206›Full record

ArticleHistochemistry and cell biology2024

Differences and similarities in biophysical and biological characteristics between U87 MG glioblastoma and astrocyte cells.

Berrin Ozdil, Duygu Calik-Kocaturk, Cisem Altunayar-Unsalan, Eda Acikgoz, Fatih Oltulu, Volkan Gorgulu, Aysegul Uysal, Gulperi Oktem, Ozan Unsalan, Gunnur Guler and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Histochemistry and cell biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Berrin OzdilDepartment of Histology and Embryology, Faculty of Medicine, Ege University, 35100, Izmir, Turkey.ORCID http://orcid.org/0000-0001-6081-2308
Duygu Calik-KocaturkDr. İsmail Fehmi Cumalioglu City Hospital, 59030, Tekirdağ, Turkey.ORCID http://orcid.org/0000-0001-5995-8967
Cisem Altunayar-UnsalanCentral Research Testing and Analysis Laboratory Research and Application Center, Ege University, 35100, Bornova, Izmir, Turkey. cisemaltunayar@gmail.com.ORCID http://orcid.org/0000-0001-6479-4223
Eda AcikgozDepartment of Histology and Embryology, Faculty of Medicine, Van Yüzüncü Yıl University, 65080, Van, Turkey.ORCID http://orcid.org/0000-0002-6772-3081
Fatih OltuluDepartment of Histology and Embryology, Faculty of Medicine, Ege University, 35100, Izmir, Turkey. fatih.oltulu@ege.edu.tr.ORCID http://orcid.org/0000-0001-6475-642X
Volkan GorguluDepartment of Histology and Embryology, Faculty of Medicine, Ege University, 35100, Izmir, Turkey.ORCID http://orcid.org/0000-0003-4026-2972
Aysegul UysalDepartment of Histology and Embryology, Faculty of Medicine, Ege University, 35100, Izmir, Turkey.ORCID http://orcid.org/0000-0002-9919-2254
Gulperi OktemDepartment of Histology and Embryology, Faculty of Medicine, Ege University, 35100, Izmir, Turkey.ORCID http://orcid.org/0000-0003-1914-2503
Ozan UnsalanDepartment of Physics, Faculty of Science, Ege University, 35100, Izmir, Turkey.ORCID http://orcid.org/0000-0001-5736-7530
Gunnur GulerDepartment of Physics, Biophysics Laboratory, Izmir Institute of Technology, 35430, Izmir, Turkey.ORCID http://orcid.org/0000-0002-8485-7372
Huseyin AktugDepartment of Histology and Embryology, Faculty of Medicine, Ege University, 35100, Izmir, Turkey.ORCID http://orcid.org/0000-0003-4150-8495
Ege University · TRIzmir Institute of Technology · TRSüleyman Demirel University · TRVan Yüzüncü Yıl Üniversitesi · TR

Funding

Ege University Research Foundation 18-tıp-013Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 117S578
6 · The paper itself

Abstract

Current cancer studies focus on molecular-targeting diagnostics and interactions with surroundings; however, there are still gaps in characterization based on topological differences and elemental composition. Glioblastoma (GBM cells; GBMCs) is an astrocytic aggressive brain tumor. At the molecular level, GBMCs and astrocytes may differ, and cell elemental/topological analysis is critical for identifying potential new cancer targets. Here, we used U87 MG cells for GBMCS. U87 MG cell lines, which are frequently used in glioblastoma research, are an important tool for studying the various features and underlying mechanisms of this aggressive brain tumor. For the first time, atomic force microscopy (AFM), scanning electron microscopy (SEM) accompanied by energy-dispersive X-ray spectroscopy (EDS), and X-ray photoelectron spectroscopy (XPS) are used to report the topology and chemistry of cancer (U87 MG) and healthy (SVG p12) cells. In addition, F-actin staining and cytoskeleton-based gene expression analyses were performed. The degree of gene expression for genes related to the cytoskeleton was similar; however, the intensity of F-actin, anisotropy values, and invasion-related genes were different. Morphologically, GBMCs were longer and narrower while astrocytes were shorter and more disseminated based on AFM. Furthermore, the roughness values of these cells differed slightly between the two call types. In contrast to the rougher astrocyte surfaces in the lamellipodial area, SEM-EDS analysis showed that elongated GBMCs displayed filopodial protrusions. Our investigation provides considerable further insight into rapid cancer cell characterization in terms of a combinatorial spectroscopic and microscopic approach.

Indexed as

Brain NeoplasmsGlioblastomaActinsAstrocytesCell Line, TumorHumansActinsAFMAstrocytesGBMSEM/EDSXPS

Identifiers

PMID37700206
OpenAlexW4386691857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.